Skip to content

Application of Individualized Exercise Prescription in the Comprehensive Management of Diabetic Obesity Patients: A Randomized Controlled Trial

Application of Individualized Exercise Prescription in the Comprehensive Management of Diabetic Obesity Patients: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000620
Enrollment
Unknown
Registered
2026-03-19
Start date
2026-09-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Experimental group:Structured exercise
Control group:Unstructured random movement

Sponsors

Hospital of Chengdu University of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Age between 18 and 75 years, regardless of gender; 2) Diagnosed with type 2 diabetes according to WHO criteria within the past 2 years; 3) HbA1c level between 6.5% and 9.0% (expressed as a proportion of total hemoglobin, multiplied by 0.01); 4) Body Mass Index (BMI; calculated as weight in kilograms divided by the square of height in meters) between 28-40 kg/m²; 5) Good compliance and able to be followed up for 6 months; 6) Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Presence of one or more of the following complications: severe proliferative diabetic retinopathy or worse, active foot ulcers, significant albuminuria (urine albumin-to-creatinine ratio = 300 mg/g), or renal dysfunction (eGFR = 60 ml/min/1.73m²); 2) History of cardiovascular events, including myocardial infarction, percutaneous coronary intervention, unstable angina, heart failure, and cardiac dysfunction; 3) Active viral hepatitis, AIDS, syphilis, and other sexually transmitted diseases, as well as infectious diseases such as tuberculosis; 4) Presence of exercise contraindications (e.g., severe osteoporosis, uncontrolled arthritis); 5) Cognitive impairment or mental illness that prevents participation in interventions; 6) Participation in other clinical trials within the past 3 months; 7) Other conditions that do not meet the trial criteria, such as physical disabilities or severe chronic illnesses (cancer, hypertension, etc.); 8) Currently pregnant, breastfeeding, or planning pregnancy; 9) Unstable weight in the 3 months prior to the study (weight increase or decrease > 4%); 10) Currently reporting more than 75 minutes of high-intensity exercise per week or 150 minutes of moderate-intensity exercise per week; 11) Night shift work; 12) History of eating disorders; 13) Average weekly alcohol intake: men >140g, women >70g; 14) Unsuitable for exercise if blood sugar is too high (fasting >16.7 mmol/L or random >20 mmol/L) or too low (<3.9 mmol/L), as it may trigger acute complications; 15) Any other conditions that, in the investigator's judgment, may interfere with study compliance.

Design outcomes

Primary

MeasureTime frame
HbA1c;

Secondary

MeasureTime frame
Fasting blood glucose;Fasting C-peptide;Average blood glucose fluctuation;Diabetes Quality of Life Scale;Body weight;Waist circumference;Blood lipid profile test;Body fat percentage;Blood pressure;Maximum oxygen uptake;6-minute walk test distance;

Countries

China

Contacts

Public ContactLiu Ya

Hospital of Chengdu University of TCM

Liuyaya918@163.com18908185918

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026